StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
JNJ

Johnson & Johnson

JNJ NYSE Pharmaceutical Preparations EDGAR ↗
$254.41
-1.41 -0.55%

Key statistics

from XBRL data in SEC filings
Market cap
$613B
Revenue (TTM)
$97.9B
Net income (TTM)
$21.0B
EPS (TTM)
$8.61
P/E ratio
29.5
Dividend yield
2.06%
Free cash flow
$19.7B
Cash
$20.4B
Total assets
$201B
Gross margin
67.9%
52-week range
$166.64 – $274.90

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 29, 2026 8-K Regulation FD disclosure Jul 28, 2026 10-Q Quarter ended 2026-06-28 Jul 23, 2026 8-K Results of operations (earnings release) Jul 15, 2026 8-K Shareholder vote results Apr 28, 2026 10-Q Quarter ended 2026-03-29 Apr 22, 2026 8-K Results of operations (earnings release); Other events Apr 14, 2026 10-K Fiscal year ended 2025-12-28 Feb 11, 2026 8-K Results of operations (earnings release) Jan 21, 2026 10-Q Quarter ended 2025-09-28 Oct 22, 2025 8-K Results of operations (earnings release); Other events Oct 14, 2025 8-K Director or officer change Sep 9, 2025 10-Q Quarter ended 2025-06-29 Jul 24, 2025 8-K Results of operations (earnings release) Jul 16, 2025 8-K Director or officer change Jun 10, 2025 8-K Director or officer change; Shareholder vote results Apr 30, 2025 10-Q Quarter ended 2025-03-30 Apr 23, 2025 8-K Results of operations (earnings release); Other events Apr 15, 2025 8-K Regulation FD disclosure Apr 3, 2025 8-K Other events Feb 26, 2025 8-K Other events Feb 20, 2025 10-K Fiscal year ended 2024-12-29 Feb 13, 2025 8-K/A Jan 22, 2025 8-K Results of operations (earnings release) Jan 22, 2025 10-Q Quarter ended 2024-09-29 Oct 23, 2024 8-K Results of operations (earnings release) Oct 15, 2024 8-K Regulation FD disclosure Sep 20, 2024 8-K Director or officer change Sep 10, 2024 8-K Director or officer change Aug 26, 2024 10-Q Quarter ended 2024-06-30 Jul 25, 2024 8-K Results of operations (earnings release) Jul 17, 2024 8-K Other events May 20, 2024 8-K Other events May 17, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2024 8-K Amended charter or bylaws; Shareholder vote results Apr 29, 2024 8-K/A Apr 16, 2024 8-K Results of operations (earnings release); Other events Apr 16, 2024 10-K Fiscal year ended 2023-12-31 Feb 16, 2024 8-K Results of operations (earnings release) Jan 23, 2024